Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Irritable Bowel Syndrome, July 2017

Free Subscription


Abstracts

Retrieve all available abstracts of the following 82 articles:
HTML format


 

Single Articles

  1. VIJAYVARGIYA P, Busciglio I, Burton D, Donato L, et al
    Bile Acid Deficiency in Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
    Clin Gastroenterol Hepatol. 2017 Jun 27. pii: S1542-3565(17)30786.
    Abstract    

    Abstract available

  2. FELICE VD, O'Mahony SM
    The microbiome and disorders of the central nervous system.
    Pharmacol Biochem Behav. 2017 Jun 27. pii: S0091-3057(17)30024.
    Abstract    

    Abstract available

  3. LOO GH, Mohamad Abu Zeid WM, Lim SL, Ismail AM, et al
    Rare presentation of idiopathic duodenoduodenal intussusception.
    Ann R Coll Surg Engl. 2017;99:e188-e190.
    Abstract    

    Abstract available

  4. SCHURMAN JV, Karazsia BT, Friesen CA
    Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
    Neurogastroenterol Motil. 2017 Jun 28. doi: 10.1111/nmo.13126.
    Abstract    

    Abstract available

  5. CHANG L
    Updates to the Rome Criteria for Irritable Bowel Syndrome.
    Gastroenterol Hepatol (N Y). 2017;13:304-306.
    Abstract    



  6. CAETANO AC, Oliveira D, Gomes Z, Mesquita E, et al
    Psychometry and Pescatori projective test in coloproctological patients.
    Ann Gastroenterol. 2017;30:433-437.
    Abstract    

    Abstract available

  7. IERARDI E, Losurdo G, Iannone A, Piscitelli D, et al
    Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?
    Ann Gastroenterol. 2017;30:380-392.
    Abstract    

    Abstract available

  8. HALKJAER SI, Boolsen AW, Gunther S, Christensen AH, et al
    Can fecal microbiota transplantation cure irritable bowel syndrome?
    World J Gastroenterol. 2017;23:4112-4120.
    Abstract    

    Abstract available

  9. ICENHOUR A, Witt ST, Elsenbruch S, Lowen M, et al
    Brain functional connectivity is associated with visceral sensitivity in women with Irritable Bowel Syndrome.
    Neuroimage Clin. 2017;15:449-457.
    Abstract    

    Abstract available

  10. ZINGONE F, Iovino P, Santonicola A, Gallotta S, et al
    High risk of lower urinary tract symptoms in patients with irritable bowel syndrome.
    Tech Coloproctol. 2017 Jun 24. doi: 10.1007/s10151-017-1653.
    Abstract    

    Abstract available

  11. WASILUK D, Ostrowska L, Stefanska E, Janke A, et al
    Diet for women with irritable bowel syndrome - a preliminary study
    Rocz Panstw Zakl Hig. 2017;68:151-160.
    Abstract    

    Abstract available

  12. IIZUKA K
    The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism.
    Nutrients. 2017;9.
    Abstract    

    Abstract available

  13. HALAWI H, Camilleri M
    Pharmacogenetics and the treatment of functional gastrointestinal disorders.
    Pharmacogenomics. 2017 Jul 7. doi: 10.2217/pgs-2017-0049.
    Abstract    

    Abstract available

  14. AYYADURAI S, Gibson AJ, D'Costa S, Overman EL, et al
    Frontline Science: Corticotropin-releasing factor receptor subtype 1 is a critical modulator of mast cell degranulation and stress-induced pathophysiology.
    J Leukoc Biol. 2017 Jul 6. pii: jlb.2HI0317.
    Abstract    

    Abstract available

  15. COSTANTINI R, Affaitati G, Wesselmann U, Czakanski P, et al
    Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients.
    Pain. 2017 Jul 3. doi: 10.1097/j.pain.0000000000000992.
    Abstract    

    Abstract available

  16. SCHWEIGER V, Del Balzo G, Raniero D, De Leo D, et al
    Current trends in disability claims due to fibromyalgia syndrome.
    Clin Exp Rheumatol. 2017;35 Suppl 105:119-126.
    Abstract    

    Abstract available

  17. AASBRENN M, Hogestol I, Eribe I, Kristinsson J, et al
    Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study.
    BMC Obes. 2017;4:22.
    Abstract    

    Abstract available

  18. BHANDARE RR
    Cardiovascular Concern of 5-HT2B Receptor and Recent Vistas in the Development of Its Antagonists.
    Cardiovasc Hematol Disord Drug Targets. 2017.
    Abstract    

    Abstract available

  19. MUJAGIC Z, Jonkers DMAE, Ludidi S, Keszthelyi D, et al
    Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome.
    Neurogastroenterol Motil. 2017 Jul 3. doi: 10.1111/nmo.13137.
    Abstract    

    Abstract available

  20. JAYARAMAN T, Wong RK, Drossman DA, Lee YY, et al
    Communication breakdown between physicians and IBS sufferers: what is the conundrum and how to overcome it?
    J R Coll Physicians Edinb. 2017;47:138-141.
    Abstract    

    Abstract available

  21. MALTZ F, Fidler B
    Eluxadoline (Viberzi): A Mu-Opioid Receptor Agonist for the Treatment Of Irritable Bowel Syndrome With Diarrhea.
    P T. 2017;42:438-442.
    Abstract    

    Abstract available

  22. LEE C, Doo E, Choi JM, Jang SH, et al
    The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis.
    J Neurogastroenterol Motil. 2017;23:349-362.
    Abstract    

    Abstract available

  23. GHOSHAL UC
    Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros.
    J Neurogastroenterol Motil. 2017;23:334-340.
    Abstract    

    Abstract available

  24. ROSTAMI A, Riahi SM, Haghighi A, Saber V, et al
    The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis.
    Parasitol Res. 2017 Jul 1. doi: 10.1007/s00436-017-5535.
    Abstract    

    Abstract available

  25. ESWARAN S, Chey WD, Jackson K, Pillai S, et al
    A Diet Low in Fermentable Oligo-, Di-, and Mono-saccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients with Irritable Bowel Syndrome and Diarrhea.
    Clin Gastroenterol Hepatol. 2017 Jun 28. pii: S1542-3565(17)30791.
    Abstract    

    Abstract available

  26. LENHART A, Chey WD
    A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.
    Adv Nutr. 2017;8:587-596.
    Abstract    

    Abstract available

  27. ENCK P, Frieling T, Schemann M
    [Irritable bowel syndrom - disection of a disease. A 13-steps polemic].
    Z Gastroenterol. 2017;55:679-684.
    Abstract    

    Abstract available

  28. O'KEEFFE M, Jansen C, Martin L, Williams M, et al
    Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome.
    Neurogastroenterol Motil. 2017 Jul 14. doi: 10.1111/nmo.13154.
    Abstract    

    Abstract available

  29. RIBI C
    [Non-celiac wheat sensitivity - growing evidence for a wheat-dependent immune-mediated disease].
    Rev Med Suisse. 2017;13.
    Abstract    

    Abstract available

  30. BORGHINI R, Donato G, Alvaro D, Picarelli A, et al
    New insights in IBS-like disorders: Pandora's box has been opened; a review.
    Gastroenterol Hepatol Bed Bench. 2017;10:79-89.
    Abstract    

    Abstract available

  31. BORYCKA-KICIAK K, Banasiewicz T, Rydzewska G
    Butyric acid - a well-known molecule revisited.
    Prz Gastroenterol. 2017;12:83-89.
    Abstract    

    Abstract available

  32. O'TOOLE PW, Paoli M
    The contribution of microbial biotechnology to sustainable development goals: microbiome therapies.
    Microb Biotechnol. 2017 Jul 11. doi: 10.1111/1751-7915.12752.
    Abstract    

    Abstract available

  33. WU MF, Yang YW, Chen YY
    The effect of anxiety and depression on the risk of irritable bowel syndrome in migraine patients.
    J Clin Neurosci. 2017 Jul 7. pii: S0967-5868(17)30394.
    Abstract    

    Abstract available

  34. DE SILVA PS, Yang X, Korzenik JR, Goldman RH, et al
    Association of urinary phenolic compounds, inflammatory bowel disease and chronic diarrheal symptoms: Evidence from the National Health and Nutrition Examination Survey.
    Environ Pollut. 2017;229:621-626.
    Abstract    

    Abstract available

  35. ARDILL JE, Johnston BT, McCance DR, Eatock M, et al
    Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
    Ann Clin Biochem. 2017;54:297-301.
    Abstract    

    Abstract available

  36. ROSTAMI A, Riahi SM, Haghighi A, Saber V, et al
    Erratum to: the role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis.
    Parasitol Res. 2017 Jul 18. doi: 10.1007/s00436-017-5556.
    Abstract    



  37. SEBASTIAN SANCHEZ B, Gil Roales-Nieto J, Ferreira NB, Gil Luciano B, et al
    New psychological therapies for irritable bowel syndrome: mindfulness, acceptance and commitment therapy (ACT).
    Rev Esp Enferm Dig. 2017;109.
    Abstract    

    Abstract available

  38. SPAGNUOLO R, Cosco C, Mancina RM, Ruggiero G, et al
    Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome.
    Eur Rev Med Pharmacol Sci. 2017;21.
    Abstract    

    Abstract available

  39. PASSOS MDCF, Moraes-Filho JP
    INTESTINAL MICROBIOTA IN DIGESTIVE DISEASES.
    Arq Gastroenterol. 2017 Jul 6:0. doi: 10.1590/S0004-2803.201700000.
    Abstract    

    Abstract available

  40. MOSLI M, Bamarhul M, Alharbi A, Shafei S, et al
    Screening irritable bowel syndrome patients for symptoms predictive of crohn's disease using the red flag score.
    Saudi J Gastroenterol. 2017;23:229-232.
    Abstract    

    Abstract available

  41. VINCENZI M, Del Ciondolo I, Pasquini E, Gennai K, et al
    Effects of a Low FODMAP Diet and Specific Carbohydrate Diet on Symptoms and Nutritional Adequacy of Patients with Irritable Bowel Syndrome: Preliminary Results of a Single-blinded Randomized Trial.
    J Transl Int Med. 2017;5:120-126.
    Abstract    

    Abstract available

  42. KERCKHOVE N, Scanzi J, Pereira B, Ardid D, et al
    Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial.
    BMJ Open. 2017;7:e015380.
    Abstract    

    Abstract available

  43. MARBURY TC, Berg JK, Dove LS, Covington PS, et al
    Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics.
    J Clin Pharmacol. 2017 Jul 18. doi: 10.1002.
    Abstract    



  44. PARK SH, Naliboff BD, Shih W, Presson AP, et al
    Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response.
    Neurogastroenterol Motil. 2017 Jul 18. doi: 10.1111/nmo.13155.
    Abstract    

    Abstract available

  45. GHIASI F, Amra B, Sebghatollahi V, Azimian F, et al
    Association of irritable bowel syndrome and sleep apnea in patients referred to sleep laboratory.
    J Res Med Sci. 2017;22:72.
    Abstract    

    Abstract available

  46. WALKER LS, Stone AL, Smith CA, Bruehl S, et al
    Interacting influences of gender and chronic pain status on parasympathetically mediated heart rate variability in adolescents and young adults.
    Pain. 2017;158:1509-1516.
    Abstract    

    Abstract available

  47. TIGCHELAAR EF, Mujagic Z, Zhernakova A, Hesselink MAM, et al
    Habitual diet and diet quality in Irritable Bowel Syndrome: A case-control study.
    Neurogastroenterol Motil. 2017 Jul 17. doi: 10.1111/nmo.13151.
    Abstract    

    Abstract available

  48. PARTHASARATHY G, Chen J, Chia N, O'Connor HM, et al
    Reproducibility of assessing fecal microbiota in chronic constipation.
    Neurogastroenterol Motil. 2017 Jul 28. doi: 10.1111/nmo.13172.
    Abstract    

    Abstract available

  49. MIKOLASEK M, Berg J, Witt CM, Barth J, et al
    Effectiveness of Mindfulness- and Relaxation-Based eHealth Interventions for Patients with Medical Conditions: a Systematic Review and Synthesis.
    Int J Behav Med. 2017 Jul 27. doi: 10.1007/s12529-017-9679.
    Abstract    

    Abstract available

  50. TELEB M, Kuppast B, Spyridaki K, Liapakis G, et al
    Synthesis of 2-imino and 2-hydrazono thiazolo[4,5-d]pyrimidines as corticotropin releasing factor (CRF) antagonists.
    Eur J Med Chem. 2017;138:900-908.
    Abstract    

    Abstract available

  51. ASANO T, Tanaka KI, Tada A, Shimamura H, et al
    Ameliorative effect of chlorpromazine hydrochloride on visceral hypersensitivity in rats: possible involvement of 5-HT2A receptor.
    Br J Pharmacol. 2017 Jul 27. doi: 10.1111/bph.13960.
    Abstract    

    Abstract available

  52. DOULBERIS M, Saleh C, Beyenburg S
    Is there an Association between Migraine and Gastrointestinal Disorders?
    J Clin Neurol. 2017;13:215-226.
    Abstract    

    Abstract available

  53. VERA I, Judez FJ
    Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective.
    Rev Esp Enferm Dig. 2017 Jul 27. doi: 10.17235/reed.2017.5078/2017.
    Abstract    

    Abstract available

  54. WASILEWSKI A, Misicka A, Sacharczuk M, Fichna J, et al
    Prosecretory effect of loperamide in ileal and colonic mucosae of mice displaying high or low swim stress-induced analgesia associated with high and low endogenous opioid system activity.
    Neurogastroenterol Motil. 2017 Jul 26. doi: 10.1111/nmo.13166.
    Abstract    

    Abstract available

  55. RAEDSCH R, Vinson B, Ottillinger B, Holtmann G, et al
    Early onset of efficacy in patients with functional and motility-related gastrointestinal disorders : A noninterventional study with Iberogast(R).
    Wien Med Wochenschr. 2017 Jul 25. doi: 10.1007/s10354-017-0578.
    Abstract    

    Abstract available

  56. PLETIKOSIC TONCIC S, Tkalcic M
    A Measure of Suffering in relation to Anxiety and Quality of Life in IBS Patients: Preliminary Results.
    Biomed Res Int. 2017;2017:2387681.
    Abstract    

    Abstract available

  57. HARVIE RM, Chisholm AW, Bisanz JE, Burton JP, et al
    Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs.
    World J Gastroenterol. 2017;23:4632-4643.
    Abstract    

    Abstract available

  58. KAWOOS Y, Wani ZA, Kadla SA, Shah IA, et al
    Psychiatric Comorbidity in Patients With Irritable Bowel Syndrome at a Tertiary Care Center in Northern India.
    J Neurogastroenterol Motil. 2017 Jul 21. doi: 10.5056/jnm16166.
    Abstract    

    Abstract available

  59. BHESANIA N, Cresci GAM
    A nutritional approach for managing irritable bowel syndrome.
    Curr Opin Pediatr. 2017 Jul 21. doi: 10.1097/MOP.0000000000000536.
    Abstract    

    Abstract available

  60. WEGH CAM, Schoterman MHC, Vaughan EE, Belzer C, et al
    The effect of fiber and prebiotics on children's gastrointestinal disorders and microbiome.
    Expert Rev Gastroenterol Hepatol. 2017.
    Abstract    

    Abstract available

  61. MAZZAWI T, El-Salhy M
    Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance.
    Exp Biol Med (Maywood). 2017;242:1355-1362.
    Abstract    

    Abstract available

  62. WHITEHEAD SJ, Ford C, Gama RM, Ali A, et al
    Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.
    J Clin Pathol. 2017 Jul 22. pii: jclinpath-2017-204340.
    Abstract    

    Abstract available

  63. NOVOA-SANDOVAL P, Perez-Acuna K, Achata-Espinoza M, Toro-Huamanchumo CJ, et al
    [Irritable bowel syndrome in medical students from Latin America: an overlooked problem?]
    Rev Gastroenterol Peru. 2017;37:190-191.
    Abstract    



  64. EL-SALHY M, Ystad SO, Mazzawi T, Gundersen D, et al
    Dietary fiber in irritable bowel syndrome (Review).
    Int J Mol Med. 2017 Jul 19. doi: 10.3892/ijmm.2017.3072.
    Abstract    

    Abstract available

  65. ZHAO YJ, Li JH, Hu B, Wang Y, et al
    Extracellular signal-regulated kinase activation in the spinal cord contributes to visceral hypersensitivity induced by craniofacial injury followed by stress.
    Neurogastroenterol Motil. 2017 Jul 21. doi: 10.1111/nmo.13161.
    Abstract    

    Abstract available

  66. CHEY WD
    SYMPOSIUM REPORT: An Evidence-Based Approach to IBS and CIC: Applying New Advances to Daily Practice: A Review of an Adjunct Clinical Symposium of the American College of Gastroenterology Meeting October 16, 2016 * Las Vegas, Nevada.
    Gastroenterol Hepatol (N Y). 2017;13.
    Abstract    

    Abstract available

  67. KROGSGAARD LR, Lyngesen M, Bytzer P
    Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right. Authors' reply.
    Aliment Pharmacol Ther. 2017;46:386-387.
    Abstract    



  68. GIBSON PR, Halmos EP, Muir JG
    Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome-getting the facts right.
    Aliment Pharmacol Ther. 2017;46:385-386.
    Abstract    



  69. POLSTER A, Van Oudenhove L, Jones M, Ohman L, et al
    Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
    Aliment Pharmacol Ther. 2017 Jul 3. doi: 10.1111/apt.14207.
    Abstract    

    Abstract available

  70. VIJAYVARGIYA P, Camilleri M, Carlson P, Lueke A, et al
    Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
    Aliment Pharmacol Ther. 2017 Jul 10. doi: 10.1111/apt.14214.
    Abstract    

    Abstract available

  71. GENTRY J, Sherwood L, Haynes J
    Gluten-Free Diet for Irritable Bowel Syndrome.
    Am Fam Physician. 2017;96:52.
    Abstract    



  72. UNO Y
    Enigma of Intestinal Gas in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2017;112:1166-1167.
    Abstract    



  73. LOPETUSO LR, Petito V, Graziani C, Schiavoni E, et al
    Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders?
    Dig Dis. 2017 Jul 7. doi: 10.1159/000477205.
    Abstract    

    Abstract available

  74. SILVESTER JA, Graff LA, Rigaux L, Bernstein CN, et al
    Symptoms of Functional Intestinal Disorders Are Common in Patients with Celiac Disease Following Transition to a Gluten-Free Diet.
    Dig Dis Sci. 2017 Jul 7. doi: 10.1007/s10620-017-4666.
    Abstract    

    Abstract available

  75. ZHOU HQ, Yao M, Chen YW, Huang JY, et al
    Functional Gastrointestinal Disorders Common Among Nurses With Poor Sleep Quality in Shanghai, China: A Pilot Study.
    Gastroenterol Nurs. 2017;40:312-319.
    Abstract    

    Abstract available

  76. BEDNARSKA O, Walter SA, Casado-Bedmar M, Strom M, et al
    Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
    Gastroenterology. 2017 Jul 12. pii: S0016-5085(17)35868.
    Abstract    

    Abstract available

  77. HEWAWASAM SP, Iacovou M, Muir JG, Gibson PR, et al
    Dietary Practices and Fodmaps in South Asia: Applicability of the Low Fodmap Diet to Patients with Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2017 Jul 12. doi: 10.1111/jgh.13885.
    Abstract    

    Abstract available

  78. FORD AC, Lacy BE, Talley NJ
    Irritable Bowel Syndrome.
    N Engl J Med. 2017;376:2566-2578.
    Abstract    



  79. LEE J, Clarke K
    Effect of clinical and laboratory parameters on quality of life in celiac patients using celiac disease-specific quality of life scores.
    Scand J Gastroenterol. 2017 Jul 7:1-5. doi: 10.1080/00365521.2017.1350283.
    Abstract    

    Abstract available

  80. CHEN B, Zhu S, Du L, He H, et al
    Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model.
    Scand J Gastroenterol. 2017 Jul 5:1-7. doi: 10.1080/00365521.2017.1342141.
    Abstract    

    Abstract available

  81. SCHNEIDER A, Rosenberger S, Bobardt J, Bungartz-Catak J, et al
    Self-help guidebook improved quality of life for patients with irritable bowel syndrome.
    PLoS One. 2017;12:e0181764.
    Abstract    

    Abstract available

  82. BRUN P, Scarpa M, Marchiori C, Sarasin G, et al
    Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
    PLoS One. 2017;12:e0181863.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;